sophoflavescenol and Erectile-Dysfunction

sophoflavescenol has been researched along with Erectile-Dysfunction* in 1 studies

Other Studies

1 other study(ies) available for sophoflavescenol and Erectile-Dysfunction

Article	Year
2-Phenylquinazolin-4(3H)-one, a class of potent PDE5 inhibitors with high selectivity versus PDE6. Bioorganic & medicinal chemistry letters, 2009, May-15, Volume: 19, Issue:10 In our efforts to minimize the side effects associated with low selectivity against the other PDE isozymes, a novel class of 2-phenylquinazolin-4(3H)-one derivatives were designed and prepared as potent PDE5 inhibitors with high selectivity against PDE6. The syntheses and SAR studies of such molecules were reported. Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Cyclic Nucleotide Phosphodiesterases, Type 6; Erectile Dysfunction; Male; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Quinazolinones; Rats; Structure-Activity Relationship	2009

Article

Year

2-Phenylquinazolin-4(3H)-one, a class of potent PDE5 inhibitors with high selectivity versus PDE6.

Bioorganic & medicinal chemistry letters, 2009, May-15, Volume: 19, Issue:10

In our efforts to minimize the side effects associated with low selectivity against the other PDE isozymes, a novel class of 2-phenylquinazolin-4(3H)-one derivatives were designed and prepared as potent PDE5 inhibitors with high selectivity against PDE6. The syntheses and SAR studies of such molecules were reported.

Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Cyclic Nucleotide Phosphodiesterases, Type 6; Erectile Dysfunction; Male; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Quinazolinones; Rats; Structure-Activity Relationship

2009